Intratympanic versus intravenous corticosteroid treatment for sudden sensorineural hearing loss in diabetic patients: proposed study protocol for a prospective, randomized superiority trial

BACKGROUND: Diabetes mellitus is associated with risk of sudden sensorineural hearing loss (SSNHL). Systemic and intratympanic corticosteroids are the two primary treatments for SSNHL in patients with diabetes mellitus. The benefit of intratympanic compared to systemic treatment is the reduced syste...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Weiqiang, Li, Xiaoling, Zhong, Jiatao, Mei, Xueshuang, Liu, Hongyu, Yang, Le, Lu, Liming, Hu, Hongyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6998247/
https://www.ncbi.nlm.nih.gov/pubmed/32014060
http://dx.doi.org/10.1186/s13063-020-4077-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6998247/
https://www.ncbi.nlm.nih.gov/pubmed/32014060
http://dx.doi.org/10.1186/s13063-020-4077-x

Ejemplares similares